key: cord-0788584-8ti7wn9u authors: Dauletbaev, Nurlan; Zoe Oftring, S.; Akik, Wided; Michaelis-Braun, Lukas; Korel, Julia; Lands, Larry C.; Waldmann, Susanne; Müller, Beate S.; Dreher, Michael; Rohde, Gernot; Vogelmeier, Claus F.; Kuhn, Sebastian title: A scoping review of mHealth monitoring of pediatric bronchial asthma before and during COVID-19 pandemic date: 2022-01-17 journal: Paediatr Respir Rev DOI: 10.1016/j.prrv.2022.01.002 sha: 30868f55767c41652aed34ebcb42f85fb90616d3 doc_id: 788584 cord_uid: 8ti7wn9u Mobile (m) Health technology is well-suited for Remote Patient Monitoring (RPM) in a patient’s habitual environment. In recent years there have been fast-paced developments in mHealth-enabled pediatric RPM, especially during the COVID-19 pandemic, necessitating evidence synthesis. To this end, we conducted a scoping review of clinical trials that had utilized mHealth-enabled RPM of pediatric asthma. MEDLINE, Embase and Web of Science were searched from September 1, 2016 through August 31, 2021. Our scoping review identified 25 publications that utilized synchronous and asynchronous mHealth-enabled RPM in pediatric asthma, either involving mobile applications or via individual devices. The last three years has seen the development of evidence-based, multidisciplinary, and participatory mHealth interventions. The quality of the studies has been improving, such that 40% of included studies reported were randomized controlled trials. In conclusion, there exists high-quality evidence on mHealth-enabled RPM in pediatric asthma, warranting future systematic reviews and/or meta-analyses of the benefits of such RPM. The reader will come to appreciate that:  mHealth and Internet-of-Things technologies enables remote monitoring of pediatric asthma in patients' habitual environments (home, daycare or school)  This remote monitoring can be synchronous (i.e., real-time monitoring) or asynchronous (i.e., collection of health data and consultation by a healthcare professional occur at different time points)  recent mHealth apps for pediatric asthma are being developed in an evidence-based, multidisciplinary, age-tailored, and participatory manner  mHealth apps can simultaneously address multiple aspects of pediatric asthma (inhalation technique, therapy adherence control, symptom monitoring, educational content, family collaboration, etc)  If needed (e.g., nighttime or school monitoring), monitoring of pediatric asthma is feasible without smartphones and mHealth apps, by using standalone wireless devices Future research should critically appraise quantitative and qualitative benefits for the patient and clinician of mHealth monitoring in pediatric asthma. These benefits may range from traditional benchmarks (such as, symptom score, number of asthma exacerbations, pulmonary function tests) to qualitative outcomes (better collaboration between patient + parent or caregiver and a healthcare professional, sense of better autonomy over health-related decisions, etc). Future research should also define the evidence-based and age-tailored guidelines for mHealth apps for pediatric asthma. Digital health interventions have increasingly been permeating into patient care, enabling the development of novel healthcare concepts, including in the field of remote patient monitoring (RPM) . Mobile (m) Health is part of the aforementioned digital health interventions. Drawing from capacities of mobile and wireless digital technologies, mHealth supports the transfer of the concepts of patient care, public health, disease management, and health education to patients' homes, or places of study or work. When mHealth technology is combined with portable (wearable, implantable, etc) digital sensors, it enables RPM in the patients' habitual environment. Most frequently, RPM via mHealth technologies involves the use of smartphones and specialized mobile apps but can also be carried out through standalone wireless devices. This RPM can be asynchronous (that is, when a medical practitioner checks patient's health data at time points different from collection) or synchronous (i.e., a real-time remote observation of patient health data) [1] [2] [3] . Implementation of mHealth monitoring in a pediatric setting provides specific challenges, including reliance on support from a parent or caregiver, difficulty of RPM during schooltime, and requirements to the software and hardware to be tailored to the appropriate age groups. In addition, it has been a common recent trend that development of novel technological advancements outpaces the appropriate clinical testing 4 . Moreover, these fast-paced developments have been accelerated during the ongoing COVID-19 pandemic. All this justified conducting a comprehensive synthesis of the recently published evidence on mHealth monitoring in the pediatric respiratory disease. As the first step towards this objective, this scoping review aggregated and synthesized the recent available evidence of mHealth monitoring in pediatric asthma, including during the time of COVID-19 pandemic. Primary objectives: We pursued the following primary objectives. The first primary objective was to obtain an overview of relative abundance of publications on mHealth monitoring in common respiratory diseases in the pediatric population. The second primary objective was to aggregate the published data on synchronous and asynchronous monitoring, be it RPM involving mHealth apps or via standalone (e.g., Internet-of-Things) devices. The third primary objective was to yield a structured synthesis of mHealth apps tailored to children and adolescents. Secondary objective: A secondary objective was to reach an informed decision as to whether a systematic review on the pediatric mHealth is warranted by the quantity and quality of the available evidence. We were interested to know which disease or medical condition a future systematic review should cover, and whether there are clinical trials of sufficient quality for critical appraisal of evidence of the benefits of mHealth-enabled RPM. Towards the first primary objective, we wished to gauge the number of publications for common chronic pediatric respiratory diseases that would be identified by our search strategies (see below). Depending on the number of potential hits, a combined scoping review on several chronic respiratory diseases could be carried out, or the scoping review would focus on pediatric respiratory disease with the most hits. The latter was presumed to be pediatric asthma. The other common chronic pediatric respiratory diseases and conditions were bronchopulmonary dysplasia, cystic fibrosis and bronchiectasis, malformations (e.g., congenital cystic adenomatoid malformation, congenital diaphragmatic hernia, tracheomalacia, or tracheal stenosis), non-cystic fibrosis genetic diseases (e.g., alpha 1antitrypsin deficiency, sickle cell anemia, ciliary dyskinesia, Duchenne muscular dystrophy), and home ventilation and neonatal respiratory distress syndrome. In addition, we also wished to conduct a search on mHealth monitoring in pediatric COVID-19. To this end, we conducted a pilot search in MEDLINE. The MEDLINE search utilized Medical Subject Headings (MeSH) and Supplementary Concepts, as well as free-text keywords (Supplemental Table 1 ). Given the relative recent introduction of mHealth technology for RPM in pediatric chronic respiratory diseases, we limited the timeframe of the search for chronic diseases and conditions to the last 5 years (2016-09-01 to 2021-08-31; Supplemental Table 1 ). Since COVID-19 pandemic has been going on for about two years, the search was limited to the timeframe between 2020-01-01 and 2021-08-31 (Supplemental Table 1 ). To ensure the relevance of search terminology, we consulted previous systematic reviews and/or scoping reviews and/or narrative reviews on this subject (e.g., 5-7 ), or bibliography recommendations on specialized websites (e.g., 8 ). Our COVID-19 search has been described previously 9 . This search was tested in two different concepts. The first concept aimed for higher sensitivity 10 . The "high sensitivity" search concept was a modification from the popular PICO (Population, Intervention, Comparator, Outcome) criteria 11 and included only "Population" and "Intervention" (PI; Supplemental Table 1 ). The second concept aimed for higher precision 10 and included "Population", "Intervention", and "Outcome" (PIO; Supplemental Table 1 ). In both search concepts, "Population" encompassed the common chronic respiratory diseases and conditions, plus COVID-19 (Supplemental Table 1 ). The "Intervention" comprehensively addressed various definitions of mHealth, in conjunction with related terminology for individual devices and sensors (Supplemental Table 1 ). The "Outcome" encompassed different objectives of mHealth-enabled RPM, such as patient triage, timely recognition of disease exacerbation, etc (Supplemental Table 1 ). Methodologically, the comprehensive search, and the following literature screening and synthesis followed the recommendations and guidelines for scoping reviews [13] [14] [15] [16] [17] [18] , especially the PRISMA recommendation for scoping reviews (Supplemental Table 2 for PRISMA-ScR Checklist). The most important criterion for inclusion in this scoping review was that the publication had had to present a quantitative, qualitative or mixed methods intervention study which would verify the usability of the proposed digital RPM in the clinical setting relevant to the disease of interest. Thereby, many potentially interesting publications that primarily focused on development of mHealth apps (or sensors, or online platforms), but featured no patient studies, or tested the proposed intervention only in healthy volunteers, would not be considered suitable. The other inclusion criteria were the following. First, the included publication would have to be a publication in English, French or German, and show an obvious relationship to the disease of interest (e.g., bronchial asthma), and mHealth or mHealth monitoring (Supplemental Figure 1) . Then, the publication would have to be an original publication (Supplemental Figure 1 ). For the purpose of this scoping review, we also decided to include case series with more than 5 patients (Supplemental Figure 1 ). In addition, mHealth technology presented in an included publication should be suitable for PRM, which could be synchronous or asynchronous. As RPM, we defined remote collection and transfer of digital health parameters (the so-called "digital biomarkers") with the help of one or several mHealth sensor(s), or Internet-of-Things devices, and with or without the use of an mHealth app. Finally, the publication would need to clearly identify that mHealth intervention was intended, or was suitable, for pediatric population in the disease of interest. The exclusion criteria fell into several categories: (1) language other than English, French or German ("foreign language"), (2) unsuitable patient population (e.g., only adult patients, or no separate data for children and adolescents), (3) publications focusing solely on description of mHealth app or sensor, without a supporting clinical study, (4) publications dedicated to development or a computational algorithm, website, sensor or device, (5) surveys or data mining publications. The publications in categories (2) -(5) were grouped together as "unsuitable study types". Additional exclusion criteria were: (6) healthcarerelated publications without a clinical intervention (e.g., publications on health economics or digital safety of mHealth apps; excluded as "unsuitable study types") and (7) reviews of all kinds, meta-analyses, conference abstracts, retractions, commentaries or Editorials (these were grouped together as "unsuitable publication type"). With several reviewers contributing to primary (title + abstract) screening, and with the anticipated heterogeneity in mHealth-related publications, the reviewers agreed on defining any unclear cases as potentially relevant (i.e., apply a tag "maybe" during the title and abstract screening; see below). The "maybe" tag for potentially relevant publications, while increasing the workload at the step of full-text screening, aimed to avoid false-negative exclusion. Following iterative deduplication 19 , the publications were subjected to manual screening. The Furthermore, a flow chart (Supplemental Figure 1 ) was prepared by the lead author to visually describe the screening process and selection of the reasons for publication exclusion. In addition, the lead author randomly double-checked some excluded publications to warrant the consistency of the screening by other co-reviewers. Following the primary screening, full-text publications were screened by the lead author. Towards this, an Excel table was prepared to compile the following information: the last name of the first author, the year of publication, targeted study population, brief description of mHealth device or sensor or software or platform, study design, principal reasons for exclusion (if applicable). Publications' outcomes and conclusions were also to be documented. Following exclusion of unsuitable references, the lead author descriptively compiled the information from the included full-text publications. The latter information comprised detailed description of mHealth intervention (using an app or a device / sensor), type of RPM (synchronous or asynchronous), as well as additional pertinent data. In addition to descriptive (i.e., narrative) synthesis, we aimed for produce a structured and machinesearchable synthetic dataset which would compile the essential data of mHealth monitoring. Thereby, the evidence synthesis would be available in descriptive, semi-structured, and structured forms. In some publications where the nature of mHealth intervention (e.g., app features) in the underlying clinical trials was not clear from the publication at hand, the preceding publications by the authors of these clinical trials were consulted in order to recover the missing details. In this case, some limited "snowballing" technique was applied to extract the necessary information. The principal activities related to this scoping review were conducted either in the online software Rayyan 20 or desktop version of the bibliography software Endnote (version 20.2.1. 21 , Clarivate, Philadelphia, PA, USA) The mosaic plot was generated using the package "ggmosaic" 22 in conjunction with packages "ggplot2" 23 , "svglite" 24 , and "RColorBrewer" 25 for the statistical environment R 26 and graphics user interface RStudio 27 . The PRISMA flow chart was prepared with the help of Adobe Illustrator 2021 28 . The first pilot MEDLINE search aimed at higher sensitivity and thus comprised only two search concepts, Population and Intervention. When the pertinent search criteria (Supplemental Table 1 While not required per se, we still prepared a semi-structured compendium of excluded 122 publications (Supplemental Table 4 ). This information could be useful to subsequent studies (for instance, for those developing mHealth apps). Most publications (19 out of 25, or 76% of publications) included in descriptive synthesis (Table 1) , semi-structured synthesis (Supplemental Table 5 ), and structured, machinesearchable synthesis (Supplemental Table 6 authors. An interesting app developing model has been presented in one publication 51 . In particular, this app has been developed using a "crowd-sourcing" collaboration method, such that designing, and programming of different app modules have been distributed among different volunteer programmers. The majority of included publications (15 out 25, or 60%) targeted the objective of asthma self-management. These publications, not surprisingly, only represented the studies that utilized mHealth apps [38] [39] [40] [41] [42] [43] [44] 46, 47, [49] [50] [51] [52] [53] [54] . Indeed, in the included publications, mHealth apps provided an opportunity to equip the patient with a versatile asthma control tool, whose applicability ranged from simpler tasks (e.g., quality assurance of inhalation technique, asthma treatment plan, asthma education) to more sophisticated options, such as instantaneous feedback to the patient about the level of his or her asthma control, and a timely advice from a healthcare professional (see Supplemental Table 5 for details). In addition, one publication 38 presented an mHealth platform that provided feedback to the patient and supported, via a decision-supporting software, the healthcare professional in finetuning the patient's treatment plan. Furthermore, upon the synthesis of publications on mHealth apps for pediatric asthma, we observed a clear trend towards increasing sophistication of recently developed apps. If in earlier years, some mHealth platforms were used to enable a single health-related task, such as to provide treatment feedback through SMS text messages 55 , the more recent mHealth apps comprised several interdependent asthma-related modules (e.g., for patient education, treatment plans, visualization of asthma control, instant messaging from automated RPM portals, etc.; see Supplemental Table 6 for details). Moreover, the apps incorporated specific contents (sports, etc.; Supplemental Tables 5 and 6) or features (e.g., "gamification", rewards, etc.: Supplemental Tables 5 and 6) that were tailored to address children or adolescents with asthma. Some of these apps even address disease aspects beyond the conventional patient education or self-monitoring. For instance, three included publications 41,45,47 targeted family management of pediatric asthma (that is, by actively involving parents or caregivers in the management process) or aimed to foster efficient communication between the family and a healthcare practitioner. Such complex mHealth apps for pediatric asthma were developed by the evidence-informed multidisciplinary teams and benefited from participatory patient contributions (Supplemental Tables 5 and 6 ). Finally, at least 7 (28%) publications 38, 39, 42, 43, 45, 49, 52 presented descriptions of online platforms which comprised mHealth apps and web portals. The former was utilized by the patients, while the latter by healthcare professionals. Such platforms typically enabled synchronous RPM by a healthcare professional, or even in an automated manner 38 . The more sophisticated options are surely not feasible with standalone devices that are not supported by mobile apps. Yet it appears that such devices are still capable of finding their own niche in the RPM of pediatric asthma. For instance, one publication 32 described an interesting application of a standalone device to monitor nighttime symptoms to register the premonition of an asthma exacerbation (Supplemental Table 5 ). The incoming health data were integrated by the software at the site of the telemonitoring team 31 , rather than by a peripheral mHealth app on patient's end. This setting enabled development of machine learning approaches to health data, with building a subsequent computational model for timely recognition of nighttime indicators of a budding asthma exacerbation 31 . Another publication 33 utilized a standalone device that permitted monitoring adherence to therapy nebulization in pre-school children (Supplemental Table 5 ). A third publication 36 The present scoping review aggregated and synthesized the recently published knowledge on mHealth interventions in pediatric asthma. Our searches revealed publications that had addressed several major aspects of mHealth interventions in infants, children and adolescents with asthma. Our overall impression of the included publications was that the quality of mHealth interventions has been improving. This was in contrast to conclusions by the 2017 Editorial 56 that observed only a moderate quality in most studies on mHealth in asthma. In contrast, among the publications included in this scoping review, 40% of the studies 35, [37] [38] [39] [40] [41] [42] [43] [44] (i.e., 10 out 25) utilized different types of randomized controlled study designs. Furthermore, some randomized trials had similar primary outcomes (e.g., Asthma Control Test score or exacerbation frequency; Supplemental Table 7) , potentially enabling a systematic review on this subject. Obviously, some of these studies could reach their primary outcomes, while others could not (Supplemental Table 7 ), necessitating quantitative synthesis. A further argument supporting systematic review and quantitative synthesis comes from the fact that the great majority of the publications included in our synthesis (23 out 25 publications, 92%) were published recently, that is, between 2018 and 2021. There have been systematic reviews 57-59 on a related subject, which, however, addressed telemedicine in general but not specifically mHealth. Further supporting the need for synthetic quantitative analyses on mHealth in pediatric asthma is the fact that true savings for the healthcare may be seen only after a certain number of patients utilize a digital health intervention. For example, one publication 60 estimated such a minimal number at nearly a thousand. None of the studies included in this scoping review recruited a comparable number of patients to achieve such economy of scale. In addition, the beneficial effects of mHealth interventions can go beyond just an improved control over the disease. These benefits can comprise increased health autonomy of the patient and enhanced participatory nature of the healthcare 61 [38] [39] [40] [41] 48 in this scoping review addressed labile pediatric asthma or asthma exacerbation, whereas other studies addressed the asthma in general (such as, by providing an age-tailored educational content). It is worth mentioning that the association between therapy adherence and prevention of asthma exacerbations seems not to be fully established yet. Some publications have not observed such an association 44, 65 . Other publications advocate the opinion that while asthma can exacerbate despite supreme therapy adherence 66 (potentially, due to the complex biological nature of this disease 67 ), poor adherence almost inevitably leads to poor asthma control 68 . In this regard, mHealth technology can enable an instantaneous alert about dangerous levels of extrinsic factors (e.g., pollen counts 69 , air pollution 70 , or viral factors [71] [72] [73] that commonly trigger an asthma exacerbation. While attractive, mHealth monitoring, especially if it is smartphone-and app-based, encounters certain barriers in the pediatric setting. These barriers include access to a smartphone, inability to use the phone at school, and time restrains during the school days 74 . While there are workarounds to compensate for a lack of access to a smartphone (e.g., via the use of webtools 75 ), the restrictions of school rules and schedules may be harder to overcome. Nonetheless, the interest of the patients in mHealth as a disease control tool is high 76 . Even adolescent patients, with increased self-awareness, appreciate mHealth interventions, provided that these won't draw unnecessary attention to their asthma 77 . Future studies of mHealth interventions should be able to capitalize on patients' interest and general appreciation of technology by developing evidence-based, participatory and age-tailored app contents for pediatric asthma. It is also important to consider that some sensors or devices (e.g., a spirometer) require an extensive training to obtain informative and reliable (i.e., high veracity) monitoring data. Examples of programs with such extensive trainings can be found in the literature (e.g., 78 ). An alternative is to develop mHealth devices that will require little or no training of the patient, or those that could be utilized during normal activities (e.g., during the sleep 32,79 ). Our scoping review has certain limitations. For example, we limited the literature search to published sources in the three major electronic databases. Neither grey literature nor mobile app repositories were consulted as part of this scoping review. Furthermore, we utilized only a limited "snowballing" search (such as to find out details about a particular mHealth app). In addition, our pilot search on mHealth monitoring in pediatric diseases did not include rare pediatric conditions (e.g., pediatric pulmonary fibrosis 80 ). Similarly, some systemic conditions with implications on the respiratory system (e.g., pediatric obesity-related asthma 81 ) were not explored. Nonetheless, we believe that the evidence synthesis in this scoping review convincingly demonstrated the recent trends towards development of evidence-based, interdisciplinary and participatory mHealth interventions for the pediatric patient. In conclusion, among pediatric respiratory diseases, and with the sole exception of COVID-19, asthma is the disease with the most publications on mHealth interventions accumulated to date. This scoping review presented descriptive, semi-structured, and structured synthesis of recent published evidence on mHealth monitoring in pediatric asthma. The quality of published studies on this subject has been improving in the recent years, and the employed mHealth apps increasingly become evidence-based, interdisciplinary, and participatory. Future synthetic studies, including systematic reviews and/or meta-analyses, should critically appraise the evidence of the benefits of mHealth technology in the pediatric setting, both for RPM and qualitative aspects of disease management. The funders were not involved in the design of this scoping review, and did not participate or influence the execution, analyses, interpretation of the data, the descriptive synthesis, or decisions about manuscript submission. Telehealth for Pediatric Asthma Telehealth Systems. StatPearls. Treasure Island (FL): StatPearls Publishing LLC Is telemedicine as effective as usual care? Technology interventions for nonadherence: new approaches to an old problem Digital health interventions in children with asthma Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results Assessment of postnatal corticosteroids for the prevention of bronchopulmonary dysplasia in preterm neonates: a systematic review and network meta-analysis Special Ovid filters for MEDLINE: children -focussed Implementation and use of mHealth home telemonitoring in adults with acute COVID-19 infection: a scoping review protocol Cochrane handbook for systematic reviews of interventions version 6 The well-built clinical question: a key to evidence-based decisions Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study Scoping studies: towards a methodological framework Scoping reviews: time for clarity in definition, methods, and reporting Scoping studies: advancing the methodology Preparing scoping reviews for publication using methodological guides and reporting standards PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation Guidance for conducting systematic scoping reviews De-duplication of database search results for systematic reviews in EndNote Rayyan-a web and mobile app for systematic reviews ggmosaic: mosaic plots in the 'ggplot2' framework Elegant graphics for data analysis svglite: an 'SVG' graphics device R: a language and environment for statistical computing. R Foundation for Statistical Computing Adobe Inc. Adobe Illustrator Virtual primary care implementation during COVID-19 in high-income countries: a scoping review WEARCON: wearable home monitoring in children with asthma reveals a strong association with hospital based assessment of asthma control Passive nocturnal physiologic monitoring enables early detection of exacerbations in children with asthma. A proof-of-concept study The effect of electronic monitoring combined with weekly feedback and reminders on adherence to inhaled corticosteroids in infants and younger children with asthma: a randomized controlled trial Exploring the association between self-reported asthma impact and Fitbit-derived sleep quality and physical activity measures in adolescents Novel electronic adherence monitoring devices in children with asthma: a mixed-methods study Use of wearable sensors to assess compliance of asthmatic children in response to lockdown measures for the COVID-19 epidemic Advanced counselling using training device and smartphone application on inhalation technique from metered-dose inhaler with spacer equipped with different interfaces in asthmatic children Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial A randomized controlled trial of a mobile applicationassisted nurse-led model used to improve treatment outcomes in children with asthma Dose matters: a smartphone application to improve asthma control among patients at an urban pediatric primary care clinic Using mobile Health to improve asthma self-Management in early Adolescence: a pilot randomized controlled trial Design, methods, and baseline characteristics of a pilot, randomized, controlled trial of the effects of an electronic monitoring device on medication adherence in children with asthma Sensor-based electronic monitoring for asthma: a randomized controlled trial Real-world evaluation of a mobile health application in children with asthma Conversational agents as mediating social actors in chronic disease management involving health care professionals, patients, and family members: multisite single-arm feasibility study Adaptive mobile Health intervention for adolescents with asthma: iterative user-centered development Beneficial features of a mHealth asthma app for children and caregivers: qualitative study Developing and evaluating ASTHMAXcel adventures: a novel gamified mobile application for pediatric patients with asthma Effective engagement of adolescent asthma patients with mobile health-supporting medication adherence Application of Human Augmentics: a persuasive asthma inhaler A consumer designed smartphone app for young people with asthma: pilot of engagement and acceptability Smartphone app for monitoring asthma in children and adolescents Feasibility of a novel mHealth management system to capture and improve medication adherence among adolescents with asthma Postdischarge recovery after acute pediatric lung disease can be quantified with digital biomarkers The validity and acceptability of a text-based monitoring system for pediatric asthma studies Realising the potential of mHealth to improve asthma and allergy care: how to shape the future School-based telemedicine interventions for asthma: a systematic review Telemedical asthma education and health care outcomes for school-age children: a systematic review Impact of eHealth on medication adherence among patients with asthma: a systematic review and meta-analysis Can digital communication technology reduce health system personnel time? An evaluation of personnel requirements and costs in a randomized controlled trial What is the clinical value of mHealth for patients? Evidence standards framework for digital health technologies Mobile health ethics and the expanding role of autonomy Meta-analyses: what is heterogeneity? Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma Asthma attacks in children are always preceded by poor asthma control: myth or maxim? Applying a biopsychosocial model to inner city asthma: Recent approaches to address pediatric asthma health disparities Evolution of asthma self-management programs in adolescents: from the crisis plan to Facebook Characterising non-linear associations between airborne pollen counts and respiratory symptoms from the AirRater smartphone app in Tasmania, Australia: A case time series approach The Asthma Mobile Health Study, a large-scale clinical observational study using ResearchKit Environmental factors relevant to difficult asthma All I need is the air that I breath: outdoor air quality and asthma Interventions for autumn exacerbations of asthma in children I have most of my asthma under control and I know how my asthma acts: Users' perceptions of asthma self-management mobile app tailored for adolescents Ambulatory management of childhood asthma using a novel self-management application Asthma app use and interest among patients with asthma: a multicenter study See I told you I was taking it! -Attitudes of adolescents with asthma towards a device monitoring their inhaler use: implications for future design Initiating home spirometry for children during the COVID-19 pandemic -a practical guide Tidal breathing flow profiles during sleep in wheezing children measured by impedance pneumography Approaching clinical trials in childhood interstitial lung disease and pediatric pulmonary fibrosis Paediatric obesity-related asthma: disease burden and effects on pulmonary physiology The authors declare no conflicts of interest.